Anicemol

Anicequol, a microbial secondary metabolites, is an anchorage-independent growth of tumor cells inhibitor. Anicequol inhibits the anchorage-independent growth of human colon cancer DLD-1 cells with the IC50 of 1.2 μM[1].

440368-05-8

12352211

Endogenous Metabolite

Metabolic Enzyme/Protease

Cancer

C[C@@]12[C@](C[C@@H]([C@]2([H])[C@H](C)/C=C/[C@H](C)C(C)C)OC(C)=O)([H])[C@@]3([H])[C@@]([C@H](C1)O)([H])[C@@]4([C@@](C[C@H](CC4)O)([H])C([C@@H]3O)=O)C

C30H48O6

504.70

[1]Igarashi Y, et al. Anicequol, a novel inhibitor for anchorage-independent growth of tumor cells from Penicillium aurantiogriseum Dierckx TP-F0213. J Antibiot (Tokyo) . 2002 Apr;55 (4) :371-6.

Room temperature

http://file.medchemexpress.com/batch_PDF/HY-N13886/

Natural Products

No Development Reported